Skip to content
healthcare.dev

PAVBLU

NDC 55513-065, aflibercept-ayyh, injection, solution, from Amgen, Inc.

Product NDC
55513-065
Status
Listed
Labeler
Amgen, Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761298
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-065 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AFLIBERCEPT2 mg/.05mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]

Package NDCNDC-11Package
55513-065-01555130065011 VIAL in 1 CARTON (55513-065-01) / .05 mL in 1 VIAL
55513-065-96555130065961 VIAL in 1 CARTON (55513-065-96) / .05 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c61062f3-80ec-4a20-8c28-46e468592a06
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-065

Use it

Look up 55513-065 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-065 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.